AlphAIAlphAI — Financial news for AI agents
SEC EDGAROCT 71 min read$ARQQ

Feenan Paul sold $13K of ARQQ

Feenan Paul (Chief Revenue Officer) sold 533 shares of Arqit Quantum Inc. (ARQQ) at $23.78 on 2026-10-05.

Original reporting
SEC EDGAR · Feenan Paul
Published Oct 7, 2026, 11:49 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 7, 2026, 11:52 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefInsider activity
Primary signal
$ARQQ
Bearish
medium confidence
Mentioned
$ARQQ
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ARQQBearishLow
01

Why it matters

The filing provides primary disclosure of a minor insider sell, offering limited market insight.

02

Market read

Minor insider transaction with negligible effect on stock price.

03

What to watch

CRO may be diversifying portfolio; no change in company fundamentals.

Relevance 3/10Novelty 3/10Timing: today

Background

SEC Form 4 filing shows Arqit Quantum Inc. officer Feenan Paul sold 533 shares at $23.78 each.

Company-level read

Ticker impact

$ARQQBearishMedium confidence
Context

CRO Feenan Paul sold 533 shares of ARQQ for $12,677, reducing his holding to 21,416 shares.

Expected impact

likely modest pressure as market prices in the insider sale

Evidence & confidence

Sale size is modest ($12.7k) but the seller is the Chief Revenue Officer, suggesting possible concern.

Market effects

Sector

Quantum computing sector sees minimal impact from a small insider sell.

Regional

US equity market, limited effect.

Global

Low global relevance.

Counterpoint

What could challenge this read

The sale may be routine personal liquidity and not a negative signal.

Key entities

  • company
    Arqit Quantum Inc.

    Quantum communications firm listed as ARQQ.

  • person
    Feenan Paul

    Chief Revenue Officer of Arqit Quantum Inc.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

ARQQ insider trading history →

Related articles

JUN 4
$QNTMedAI 9/10

Quantum Computing Shares Sink Ahead Of Blockbuster Quantinuum IPO

Quantinuum (QNT) shares fell Wednesday as the Honeywell-backed firm neared its Nasdaq debut, with pricing set for June 3 and first trading expected June 4. The company plans to sell 26.5 million shares at $53–$55 to raise about $1.46 billion, valuing it at up to $14.3 billion, according to the report. Other quantum stocks also declined.

finance.yahoo.com4 min
OCT 27
$LYCAMedAI 8/10

Venrock Healthcare Capital Partners III, L.P. (Koh Bong Y, Shah Nimish P) purchased $37.7M of LYCA (indirect holdings)

Venrock Healthcare Capital Partners III, L.P. purchased 2,045,440 indirectly-held shares of Lycia Therapeutics, Inc. (LYCA) at an average of $18.41 ($18.00–$26.97, $37.65M total) across 6 trades over 2026-10-23 to 2026-10-27. Filed jointly with VHCP Co-Investment Holdings III, LLC (10% owner), VHCP Management III, LLC (10% owner), Venrock Healthcare Capital Partners EG, L.P. (10% owner), VHCP Management EG, LLC (10% owner), Venrock Healthcare Capital Partners XP, L.P. (10% owner), VHCP Management XP, LLC (10% owner), Koh Bong Y (10% owner) and Shah Nimish P (10% owner).

SEC EDGAR1 min